Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactions
G Occhipinti, L Ortega-Paz, F Franchi… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction. Cangrelor, the only intravenous platelet P2Y12 receptor inhibitor, is
characterized by a prompt and potent platelet inhibition, with a rapid offset of action. Large …
characterized by a prompt and potent platelet inhibition, with a rapid offset of action. Large …
A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysis
M Geravandi, M Nourabi, S Navabifar, S Dolatshahi… - 2023 - researchsquare.com
Background Rupture of unstable coronary atherosclerotic plaque leads to acute ST segment
elevation myocardial infarction which is the most critical type of acute coronary syndrome …
elevation myocardial infarction which is the most critical type of acute coronary syndrome …
Investigation of the efficacy and safety issues of antithrombotic treatment in cardiovascular medicine
B Alexandra - 2022 - pea.lib.pte.hu
Coronary artery disease (CAD) is the foremost single cause of mortality and loss of Disability
Adjusted Life Years (DALYs) globally. A large number of this burden falls on low-and …
Adjusted Life Years (DALYs) globally. A large number of this burden falls on low-and …
Investigation of the efficacy and safety issues of antithrombotic treatment in cardiovascular medicine
A Bálint - 2022 - search.proquest.com
Coronary artery disease (CAD) is the foremost single cause of mortality and loss of Disability
Adjusted Life Years (DALYs) globally. A large number of this burden falls on low-and …
Adjusted Life Years (DALYs) globally. A large number of this burden falls on low-and …